Skip to main content
Top
Published in: Drugs & Aging 6/2010

01-06-2010 | Therapy In Practice

Diagnosis and Pharmacological Treatment of Chronic Actinic Dermatitis in the Elderly

An Update

Authors: Dr Emily L. Forsyth, Thomas P. Millard

Published in: Drugs & Aging | Issue 6/2010

Login to get access

Abstract

Chronic actinic dermatitis (CAD) describes a condition resulting from abnormal photosensitivity; the dermatitis is clinically similar to contact allergic dermatitis. Sun-exposed skin is more commonly affected but the condition can extend to and encompass unexposed skin. CAD is relatively rare but becomes more prevalent in the elderly population. Phototesting, patch testing and laboratory results should be used to help guide diagnosis. In the elderly, it is important to distinguish CAD from drug-induced photosensitivity. Management of the condition requires sunlight avoidance and use of sunscreens, topical emollients and topical corticosteroids. Oral corticosteroids and immunosuppressive therapy such as azathioprine may be indicated but should be used with caution in the elderly.
Literature
1.
go back to reference Hawk JLM, Magnus IA. Chronic actinic dermatitis: an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol 1979; 101Suppl. 17: 24PubMed Hawk JLM, Magnus IA. Chronic actinic dermatitis: an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol 1979; 101Suppl. 17: 24PubMed
2.
go back to reference Ive FA, Magnus IA, Warin RP, et al. Actinic reticuloid; a chronic dermatosis associated with severe photosensitivity and the histological resemblance to lymphoma. Br J Dermatol 1969; 81: 469–85PubMedCrossRef Ive FA, Magnus IA, Warin RP, et al. Actinic reticuloid; a chronic dermatosis associated with severe photosensitivity and the histological resemblance to lymphoma. Br J Dermatol 1969; 81: 469–85PubMedCrossRef
3.
go back to reference Ramsay CA, Kobza-Black A. Photosensitive eczema. Trans St Johns Hosp Derm Soc 1973; 59: 152–8 Ramsay CA, Kobza-Black A. Photosensitive eczema. Trans St Johns Hosp Derm Soc 1973; 59: 152–8
4.
go back to reference Frain-Bell W, Lakshmipathi T, Rogers J, et al. The syndrome of chronic photosensitivity dermatitis and actinic reticuloid. Br J Dermatol 1974; 91: 617–34PubMedCrossRef Frain-Bell W, Lakshmipathi T, Rogers J, et al. The syndrome of chronic photosensitivity dermatitis and actinic reticuloid. Br J Dermatol 1974; 91: 617–34PubMedCrossRef
5.
go back to reference Somani VK. Chronic actinic dermatitis: a study of clinical features. Indian J Dermatol Venereol Leprol 2005; 71: 409–13PubMedCrossRef Somani VK. Chronic actinic dermatitis: a study of clinical features. Indian J Dermatol Venereol Leprol 2005; 71: 409–13PubMedCrossRef
6.
go back to reference Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther 2003; 16: 45–51PubMedCrossRef Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther 2003; 16: 45–51PubMedCrossRef
7.
go back to reference Booth AV, Mengden S, Soter NA, et al. Chronic actinic dermatitis. Dermatol Online J 2008; 14(5): 25PubMed Booth AV, Mengden S, Soter NA, et al. Chronic actinic dermatitis. Dermatol Online J 2008; 14(5): 25PubMed
9.
go back to reference Menagé H, Hawk JLM. The idiopathic photodermatoses: chronic actinic dermatitis. In: Hawk JLM, editor. Photodermatology. London: Arnold, 1999: 127–42 Menagé H, Hawk JLM. The idiopathic photodermatoses: chronic actinic dermatitis. In: Hawk JLM, editor. Photodermatology. London: Arnold, 1999: 127–42
10.
11.
go back to reference Kochevar IE, Harber LC. Photoreactions of 3,3′,4′,5-tetrachlorsalicylanilide with proteins. J Invest Dermatol 1977; 68: 151–6PubMedCrossRef Kochevar IE, Harber LC. Photoreactions of 3,3′,4′,5-tetrachlorsalicylanilide with proteins. J Invest Dermatol 1977; 68: 151–6PubMedCrossRef
12.
go back to reference Dawe RS, Crombie IK, Ferguson J. The natural history of chronic dermatitis. Arch Dermatol 2000; 136: 1215–20PubMedCrossRef Dawe RS, Crombie IK, Ferguson J. The natural history of chronic dermatitis. Arch Dermatol 2000; 136: 1215–20PubMedCrossRef
13.
go back to reference Agar N, Morris S, Russell-Jones R, et al. Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol 2009; 160: 698–703PubMedCrossRef Agar N, Morris S, Russell-Jones R, et al. Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol 2009; 160: 698–703PubMedCrossRef
14.
go back to reference Menagé H, Ross JS, Norris PG, et al. Contact and photo-contact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen. Br J Dermatol 1995; 132: 543–7PubMedCrossRef Menagé H, Ross JS, Norris PG, et al. Contact and photo-contact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen. Br J Dermatol 1995; 132: 543–7PubMedCrossRef
15.
go back to reference Ferguson J. Drug and chemical photosensitivity. In: Hawk JLM, editor. Photodermatology. London: Arnold, 1999: 155–70 Ferguson J. Drug and chemical photosensitivity. In: Hawk JLM, editor. Photodermatology. London: Arnold, 1999: 155–70
16.
go back to reference Leigh IM, Hawk JL. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984; 110: 691–5PubMedCrossRef Leigh IM, Hawk JL. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984; 110: 691–5PubMedCrossRef
17.
18.
go back to reference Jong CT, Finaly AY, Pearse AD, et al. The quality of life of 790 patients with photodermatoses. Br J Dermatol 2008; 159: 192–7PubMedCrossRef Jong CT, Finaly AY, Pearse AD, et al. The quality of life of 790 patients with photodermatoses. Br J Dermatol 2008; 159: 192–7PubMedCrossRef
Metadata
Title
Diagnosis and Pharmacological Treatment of Chronic Actinic Dermatitis in the Elderly
An Update
Authors
Dr Emily L. Forsyth
Thomas P. Millard
Publication date
01-06-2010
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 6/2010
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11315930-000000000-00000

Other articles of this Issue 6/2010

Drugs & Aging 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine